Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EBOS Group Limited ( (AU:EBO) ) just unveiled an update.
EBOS Group Limited has announced the opening of its new Symbion pharmacy wholesale distribution centre in Kemps Creek, Sydney, as part of a four-year $360 million distribution centre renewal program. This state-of-the-art facility, spanning 56,000 square metres, is designed to enhance service efficiency, expand capacity, and improve operational efficiency through automation. It features advanced energy solutions, including a large rooftop solar array and bio-diesel generators, reflecting EBOS Group’s commitment to renewable energy. The new centre will serve approximately 1,500 customers in New South Wales, with the previous Sydney centre set to close by FY26. The completion of this program is expected to reduce future annual capital expenditure by 30%.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited is the largest and most diversified Australasian marketer, wholesaler, and distributor of healthcare, medical, and pharmaceutical products. It is also a leading Australasian animal care brand owner, product marketer, and distributor.
Average Trading Volume: 138,502
Technical Sentiment Signal: Sell
Current Market Cap: A$5.13B
For a thorough assessment of EBO stock, go to TipRanks’ Stock Analysis page.